Clinical Trial Update: AZD9668 Relative Bioavailability [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the relative bioavailability of AZD9668 in Chronic Obstructive Pulmonary Disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD9668 (AZD9668)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED